ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
20.317,10
0,00%
S&P 500
5.918,25
0,00%
Dow Jones
42.635,20
0,00%
Euro vs US Dollar
1,03005
-0,13%
Bitcoin
91.604,44
-3,63%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Cross Country Health (CCRN)

  7. Cross Country Health (CCRN) News

CCRN

Cross Country Health (CCRN)

Cross Country Health
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:CCRN
DatumZeitQuelleÜberschriftSymbolFirma
06/01/202523h30Edgar (US Regulatory)Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:CCRNCross Country Health
06/01/202514h16Edgar (US Regulatory)Form PREM14A - Preliminary proxy statements relating to merger or acquisitionNASDAQ:CCRNCross Country Health
03/01/202519h42Edgar (US Regulatory)Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:CCRNCross Country Health
20/12/202420h32Edgar (US Regulatory)Form SCHEDULE 13D - General Statement of Acquisition of Beneficial OwnershipNASDAQ:CCRNCross Country Health
06/12/202417h42PR Newswire (US)Kuehn Law Encourages AVAV, CCRN, MPB, and ENLC Investors to Contact Law FirmNASDAQ:CCRNCross Country Health
04/12/202423h18Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:CCRNCross Country Health
04/12/202423h16Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:CCRNCross Country Health
04/12/202423h13Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:CCRNCross Country Health
04/12/202423h05Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:CCRNCross Country Health
04/12/202422h56Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:CCRNCross Country Health
04/12/202422h54Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:CCRNCross Country Health
04/12/202422h51Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:CCRNCross Country Health
04/12/202422h50Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:CCRNCross Country Health
04/12/202414h50Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CCRNCross Country Health
04/12/202413h45Business WireAya Healthcare to Acquire Cross Country Healthcare for Approximately $615 Million in CashNASDAQ:CCRNCross Country Health
13/11/202415h45Business WireCross Country’s Susan E. Ball Recognized on SIA’s Global Power 150 Women in StaffingNASDAQ:CCRNCross Country Health
07/11/202421h59Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CCRNCross Country Health
07/11/202417h46Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:CCRNCross Country Health
06/11/202422h28Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CCRNCross Country Health
06/11/202422h15Business WireCross Country Healthcare Announces Third Quarter 2024 Financial ResultsNASDAQ:CCRNCross Country Health
24/10/202422h25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CCRNCross Country Health
24/10/202422h15Business WireCross Country Healthcare to Attend UBS Global Healthcare ConferenceNASDAQ:CCRNCross Country Health
18/10/202422h27Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CCRNCross Country Health
18/10/202422h15Business WireCross Country Healthcare to Hold Third Quarter 2024 Earnings Conference Call on Wednesday, November 6, 2024NASDAQ:CCRNCross Country Health
16/10/202413h45Business WireCross Country Named Most Loved Workplace® for Wellness by NewsweekNASDAQ:CCRNCross Country Health
03/10/202413h45Business WireCross Country Survey Reveals Digital Workforce Solutions as Key to Overcoming Healthcare Staffing CrisisNASDAQ:CCRNCross Country Health
27/09/202400h04PR Newswire (US)The Ensign Group Set to Join S&P MidCap 400; Curbline Properties & TransMedics Group to Join S&P SmallCap 600NASDAQ:CCRNCross Country Health
19/09/202413h30Business WireCross Country CEO Recognized Among Most Loved Workplace Leaders by NewsweekNASDAQ:CCRNCross Country Health
29/08/202413h45Business WireCross Country Named Most Loved Workplace® for 2024NASDAQ:CCRNCross Country Health
21/08/202422h24Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CCRNCross Country Health
 Showing the most relevant articles for your search:NASDAQ:CCRN

Kürzlich von Ihnen besucht

FX
EURUSD
Euro vs US Dollar
DBI
SDXP
SDAX
CCOM
SILVER
SILVER
USOTC
DTEGY
Deutsche Telekom (QX)
USOTC
RHHBY
Roche (QX)
NASDAQ
TSLA
Tesla
TG
D7G
Nel ASA
NASDAQ
AAPL
Apple
NYSE
MRK
Merck
COIN
DOGEUSD
Dogecoin
NYSE
XOM
Exxon Mobil
AMEX
SPY
SPDR S&P 500
TG
TUI1
Tui
TG
NOV
Novo Nordisk
TG
BAS
BASF
NASDAQ
QQQ
Invesco QQQ Trust Series 1
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten